FGF21 Mutants and Uses Thereof
US-2025136653-A1 · May 1, 2025 · US
This page is not indexed by search engines while we improve data quality.
Belouski Edward John patents
Belouski Edward John is listed as an inventor on 10 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Belouski Edward John |
| Total patents | 10 |
| First publication | Mar 1, 2016 |
| Latest publication | May 1, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
FGF21 Mutants and Uses Thereof
US-2024076333-A1 · Mar 7, 2024 · US
Methods of treating non-alcoholic steatohepatitis using FGF21 mutants
US-11840558-B2 · Dec 12, 2023 · US
Fg21 mutants and uses thereof
US-2021317176-A1 · Oct 14, 2021 · US
Methods of treating non-alcoholic steatohepatitis using FGF21 mutants
US-11072640-B2 · Jul 27, 2021 · US
FGF21 Mutants and Uses Thereof
US-2019023757-A1 · Jan 24, 2019 · US
Methods of treating of diabetes and obesity using FGF21 mutants
US-10011642-B2 · Jul 3, 2018 · US
FGF21 mutants comprising a mutation at position 98, 171 and/or 180
US-9493530-B2 · Nov 15, 2016 · US
Fgf mutants and uses thereof
US-2016168223-A1 · Jun 16, 2016 · US
FGF mutants with reduced proteolysis and aggregation
US-9273106-B2 · Mar 1, 2016 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Inc | 10 |
Top CPC classifications
Most common classification codes across this inventor's patents.